4[3]Raez L E,Lilenbaum R.New developments in chemotherapy for advanced non-small cell lung cancer[J].Curr Opin Oncol,2006,18 (2):156-161.
5[5]Anderson H,Lund B,Bach F,et al.Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer:a phase Ⅱ study[J].J Clin Oncol,1994,12 (9):1821-1826.
6[10]Ronomi P D,Finkelstcin D M,Ruckdeschel J C.et al.Combination chemochempy in stage Ⅳ non-small-cell lung cancer[J].Sem in Oncol,1999,26 (1):1-2.
7[11]Gorey J I,David R G,Paula C,et al.Gemcitabin and carboplatin in combination an updace of phase Ⅰ and phase Ⅱ studies in non-small-cell lung cancer[J].Semin Oncol,1999,26 (Supp14):12-18.
8[13]De-Vita F,Ordituda M,Matano E,et al.A phase Ⅱ study of biweekly oxaliplatin plus infusion 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients[J].Br J Cancer,2005,92 (9):1644-1649.
9[14]Leonard G D,Wright M A,Quinn M G,et al.Sumey of oxaliplatin-associatied neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer[J].BMC Cancer,2006,5 (3):116.
6Robinson K, Lambiase L, Li J, Monteiro C, Schiff M. Fatal cholestatic liver failure associated with gemcitabine therapy [J]. Dig Dis Sci,2003, 48(9): 1804-1808.
7Matsuda M, Watanabe G, Mine S, Hashimoto M. Fatal liver failure associated with gemcitabine hydrochloride therapy [ J ]. Gan To Kagaku Ryoho,2008,35(1): 157-159.
8Saif M W, Shahrokni A, Cornfeld D. Gemcitabine-induced liver fibrosis in a patient with pancreatic cancer[J].JOP,2007,8(4):460-467.
9Robinson K, Lambiase L, Li J, et al. Fatal cholestatic liver failure associated with gemcitabine therapy [ J ]. Dig Dis Sci, 2003, 48 (9) :1804-1808.
10Matsuda M, Watanabe G, Mine S, et al. Fatal liver failure associ-ated with gemcitabinehydrochloride therapy[J]. Gan To Kagaku Ryoho, 2008,35 ( 1 ) : 157-159.
